“…However, data about its in vitro activity against unusual yet clinically relevant gram-positive microbes with reduced susceptibility to vancomycin, including Listeria monocytogenes and Pediococcus, Leuconostoc, Rhodococcus, and Nocardia spp., remain scarce (3,11,13,14,18). All of these pathogens can cause invasive diseases, including bacteremia, pulmonary infections, and soft tissue infections, which usually occur in immunocompromised but occasionally in immunocompetent hosts (1,3,9,13,17).…”